The DOI matches its Crossref record; 258 of the 258 references it cites were found in a registry or an index.
Nrf2 at the heart of oxidative stress and cardiac protection
Open accessAbstract
The NFE2L2 gene encodes the transcription factor Nrf2 best known for regulating the expression of antioxidant and detoxification genes. Gene knockout approaches have demonstrated its universal cytoprotective features. While Nrf2 has been the topic of intensive research in cancer biology since its discovery in 1994, understanding the role of Nrf2 in cardiovascular disease has just begun. The literature concerning Nrf2 in experimental models of atherosclerosis, ischemia, reperfusion, cardiac hypertrophy, heart failure, and diabetes supports its cardiac protective character. In addition to antioxidant and detoxification genes, Nrf2 has been found to regulate genes participating in cell signaling, transcription, anabolic metabolism, autophagy, cell proliferation, extracellular matrix remodeling, and organ development, suggesting that Nrf2 governs damage resistance as well as wound repair and tissue remodeling. A long list of small molecules, most derived from natural products, have been characterized as Nrf2 inducers. These compounds disrupt Keap1-mediated Nrf2 ubquitination, thereby prohibiting proteasomal degradation and allowing Nrf2 protein to accumulate and translocate to the nucleus, where Nrf2 interacts with sMaf to bind to ARE in the promoter of genes. Recently alternative mechanisms driving Nrf2 protein increase have been revealed, including removal of Keap1 by autophagy due to p62/SQSTM1 binding, inhibition of βTrCP or Synoviolin/Hrd1-mediated ubiquitination of Nrf2, and de novo Nrf2 protein translation. We review here a large volume of literature reporting historical and recent discoveries about the function and regulation of Nrf2 gene. Multiple lines of evidence presented here support the potential of dialing up the Nrf2 pathway for cardiac protection in the clinic.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–258 of 258
Lee, T., Lin, S., & Chang, N. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.08.022 · Cited by 67
The role of the Nrf2-mediated defense system in corneal epithelial wound healing
Hayashi, R., Himori, N., Taguchi, K., Ishikawa, Y., Uesugi, K., Ito, M., Duncan, T., Tsujikawa, M., Nakazawa, T., Yamamoto, M. P., et al. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.04.008 · Cited by 66
Shimizu, Y., Nicholson, C. K., Lambert, J. P., Barr, L. A., Kuek, N., Herszenhaut, D., Tan, L., Murohara, T., Hansen, J. M., Husain, A., et al. (2016) · Circulation Heart Failure · doi:10.1161/circheartfailure.115.002368 · Cited by 66
Hu, T., Wei, G., Xi, M., Yan, J., Wu, X., Wang, Y., Zhu, Y., Wang, C., & Wen, A. (2021) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2021.5045 · Cited by 64
Wang, H., Lai, Y., Mathis, B. J., Wang, W., Li, S., Qu, C., Li, B., Shao, L., Song, H., Janicki, J. S., et al. (2015) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2015.04.012 · Cited by 62
Xing, Y., Niu, T., Wang, W., Li, J., Li, S., Janicki, J. S., Ruiz, S., Meyer, C. J., Wang, X. L., Tang, D., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044899 · Cited by 61
Wang, Y., Wang, H., Qian, C., Tang, J., Zhou, W., Liu, X., You, Q., & Hu, R. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2015.11.015 · Cited by 61
Zhang, B., Zhao, J. J., Li, S., Yang, L., Zeng, L.-L., Chen, Y., & Fang, J. (2013) · Acta Pharmacologica Sinica · doi:10.1038/aps.2013.165 · Cited by 60
Purdom, S., & Chen, Q. M. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.077057 · Cited by 58
Self-citationCao, Z., Zhu, H., Zhang, L., Zhao, X., Zweier, J. L., & Li, Y. (2006) · Experimental Biology and Medicine · doi:10.1177/153537020623100809 · Cited by 56
Shimoyama, Y., Mitsuda, Y., Tsuruta, Y., Hamajima, N., & Niwa, T. (2014) · International Journal of Medical Sciences · doi:10.7150/ijms.8590 · Cited by 56
La Autoantigen Mediates Oxidant Induced De Novo Nrf2 Protein Translation
Zhang, J. Y., Dinh, T. N., Kappeler, K. V., Tsaprailis, G., & Chen, Q. M. (2011) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m111.015032 · Cited by 56
Self-citationNrf2 Deficiency Impairs Fracture Healing in Mice
Lippross, S., Beckmann, R., Streubesand, N., Ayub, F., Tohidnezhad, M., Campbell, G., Kan, Y. W., Horst, F., Sönmez, T. T., Varoga, D. J., et al. (2014) · Calcified Tissue International · doi:10.1007/s00223-014-9900-5 · Cited by 53
Ginsenoside Rd mitigates myocardial ischemia-reperfusion injury via Nrf2/HO-1 signaling pathway.
Zeng, X., Li, J., & Li, Z. (2015) · Europe PMC (PubMed Central) · Cited by 52
Rahimi, K., Majoni, W., Merhi, A., & Emberson, J. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs005 · Cited by 50
Effect of Dimethyl Fumarate on the Radiation Sensitivity of Mammalian Cells in Vitro
Held, K. D., Epp, E. R., Clark, E. P., & Biaglow, J. E. (1988) · Radiation Research · doi:10.2307/3577299 · Cited by 48
Jiménez‐Osorio, A. S., González-Reyes, S., García‐Niño, W. R., Moreno-Macías, H., Rodríguez-Arellano, M. E., Vargas‐Alarcón, G., Zúñiga, J., Barquera, R., & Pedraza‐Chaverrí, J. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/7367641 · Cited by 47
Redox activation of Ref-1 potentiates cell survival following myocardial ischemia reperfusion injury
Gurusamy, N., Malik, G., Gorbunov, N. V., & Das, D. K. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.04.025 · Cited by 46
Qin, S., Chen, J.-H., Tanigawa, S., & Hou, D.-X. (2013) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201200563 · Cited by 45
Chen, W., Li, S., Li, J., Zhou, W., Wu, S., Xu, S., Cui, K., Zhang, D. D., & Liu, B. (2016) · The FASEB Journal · doi:10.1096/fj.201500109r · Cited by 45
Donnarumma, E., Bhushan, S., Bradley, J., Otsuka, H., Donnelly, E. L., Lefer, D. J., & Islam, K. N. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.116.003551 · Cited by 45
Dose-dependent deleterious and salutary actions of the Nrf2 inducer dh404 in chronic kidney disease
Vaziri, N. D., Liu, S., Farzaneh, S. H., Nazertehrani, S., Khazaeli, M., & Zhao, Y. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.04.022 · Cited by 44
Qu, C., Li, B., Lai, Y., Li, H., Windust, A. J., Hofseth, L. J., Nagarkatti, M., Nagarkatti, P. S., Wang, X. L., Tang, D., et al. (2015) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2015.04.004 · Cited by 44
ZHAO, J., ZHANG, B., LI, S., ZENG, L., CHEN, Y., & FANG, J. (2014) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2014.1696 · Cited by 43
Kuang, L., Feng, J., He, G., & Jing, T. (2013) · International Journal of Biological Sciences · doi:10.7150/ijbs.5887 · Cited by 43
Endothelial Nrf2 activation: a new target for resveratrol?
Haskó, G., & Pacher, P. (2010) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00436.2010 · Cited by 42
Seymour, E., Bennink, M. R., & Bolling, S. F. (2013) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2013.01.008 · Cited by 42
Xi, M., Jia, J.-M., Sun, H.-P., Sun, Z., Jiang, J., Wang, Y., Zhang, M., Zhu, J., Xu, L., Jiang, Z., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400944k · Cited by 42
Transcription factors NRF2 and HSF1 have opposing functions in autophagy
Naidu, S. D., Dikovskaya, D., Gaurilcikaite, E., Knatko, E. V., Healy, Z. R., Mohan, H., Koh, G., Laurell, A., Ball, G., Olagnier, D. P., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-11262-5 · Cited by 42
Darvekar, S. R., Elvenes, J., Brenne, H. B., Johansen, T., & Sjøttem, E. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085262 · Cited by 41
Xanthine oxidase as a marker of myocardial infarction
Raghuvanshi, R., Kaul, A., Negi, P. B., Mishra, A., & Misra, M. K. (2007) · Indian Journal of Clinical Biochemistry · doi:10.1007/bf02913321 · Cited by 40
Ramprasath, T., Kumar, P. H., Puhari, S. S. M., Murugan, P. S., Vasudevan, V., & Selvam, G. S. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.10.064 · Cited by 39
Zhao, Y., Wang, W., Wu, X., Ma, X., Qu, R., Chen, X., Liu, C., Liu, Y., Wang, X., Yan, P., et al. (2017) · International Immunopharmacology · doi:10.1016/j.intimp.2017.02.014 · Cited by 37
NFE2L2 polymorphisms, mortality, and metabolism in the general population
Figarska, S. M., Vonk, J. M., & Boezen, H. M. (2014) · Physiological Genomics · doi:10.1152/physiolgenomics.00178.2013 · Cited by 37
Wang, L., Su, S., Wang, L., Zhang, G., Zhang, R., Niu, Y., Guo, Y., Li, C., Jiang, W., Liu, Y., et al. (2015) · Europe PMC (PubMed Central) · Cited by 34
Li, W., Wu, W., Song, H., Wang, F., Li, H., Chen, L., Lai, Y., Janicki, J. S., Ward, K. W., Meyer, C. J., et al. (2014) · FEBS Letters · doi:10.1016/j.febslet.2014.04.046 · Cited by 32
Pendyala, L., Schwartz, G. N., Bolanowska-Higdon, W., Hitt, S., Zdanowicz, J., Murphy, M., Lawrence, D. D., & Creaven, P. J. (2001) · PubMed · Cited by 30
Zhou, S., Jin, J., Bai, T., Sachleben, L. R., Cai, L., & Zheng, Y. (2015) · Life Sciences · doi:10.1016/j.lfs.2015.05.015 · Cited by 27
Kim, S. G., Kim, Y. M., Choi, J. Y., Han, J.-Y., Jang, J. W., Cho, S.-H., Um, S. H., Chon, C. Y., Lee, D. H., Jang, J., et al. (2011) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.2011.01259.x · Cited by 27
Troponin testing after cardiac surgery.
Januzzi, J. L. (2009) · PubMed Central · Cited by 25
Dinkova‐Kostova, A. T., Cory, A. H., Bozak, R. E., Hicks, R. J., & Cory, J. G. (2006) · Cancer Letters · doi:10.1016/j.canlet.2006.01.024 · Cited by 24
Adam, M., Imboden, M., Schaffner, E., Boes, E., Kronenberg, F., Pons, M., Bettschart, R. W., Barthélemy, J., Schindler, C., & Probst-Hensch, N. M. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.11.049 · Cited by 24
NFE2L2 variations reduce antioxidant response in patients with Parkinson disease
Gui, Y., Zhang, L., Lv, W., Zhang, W., Zhao, J.-J., & Hu, X. (2016) · Oncotarget · doi:10.18632/oncotarget.7353 · Cited by 23
Wu, J. H., Miao, W., Hu, L. G., & Batist, G. (2010) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2010.00955.x · Cited by 22
The paradox of bardoxolone methyl: a call for every witness on the stand?
Laecke, S. V., Biesen, W. V., & Vanholder, R. C. (2014) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12356 · Cited by 22
Bae, S. K., Lee, S. J., Kim, Y. G., Kim, S. H., Kim, J. W., Kim, T., & Lee, M. G. (2005) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.437 · Cited by 22
Encouraging Trends in Acute Myocardial Infarction Survival in the Oldest Old
Tjia, J., Allison, J. J., Saczynski, J. S., Tisminetzky, M. S., Givens, J. L., Lapane, K. L., Lessard, D., & Goldberg, R. J. (2013) · The American Journal of Medicine · doi:10.1016/j.amjmed.2013.02.026 · Cited by 22
Kunnas, T. A., Määttä, K. M., & Nikkari, S. T. (2016) · International Journal of Medical Sciences · doi:10.7150/ijms.14849 · Cited by 22
Zhang, X., Zhao, X., & Ma, Z. (2010) · Toxicology Letters · doi:10.1016/j.toxlet.2010.08.011 · Cited by 20
Camer, D., Yu, Y., Szabo, A., Wang, H., Dinh, C. H. L., & Huang, X. (2015) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2015.11.018 · Cited by 20
Bardoxolone methyl in type 2 diabetes and advanced chronic kidney disease.
Chertow, G. M., & de Zeeuw, D. (2014) · PubMed · doi:10.1056/nejmc1400872 · Cited by 18
Williamson, T. P., Amirahmadi, S., Gururaj Joshi, A., Kaludov, N. K., Martinov, M. N., Johnson, D. A., & Johnson, J. A. (2012) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12040 · Cited by 17
The Triterpenoid RTA 408 is a Robust Mitigator of Hematopoietic Acute Radiation Syndrome in Mice
Goldman, D. C., Alexeev, V. Y., Lash, E., Guha, C., Rodeck, U., & Fleming, W. (2015) · Radiation Research · doi:10.1667/rr13900.1 · Cited by 15
Oltipraz-induced phase 2 enzyme response conserved in cells lacking mitochondrial DNA
Chua, Y. L., Zhang, D., Boelsterli, U. A., Moore, P. K., Whiteman, M., & Armstrong, J. S. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.09.059 · Cited by 11
Bardoxolone methyl in type 2 diabetes and advanced chronic kidney disease.
Chartoumpekis, D. V., & Sykiotis, G. P. (2014) · New England Journal of Medicine · doi:10.1056/nejmc1400872#sa1 · Cited by 11
Kappeler, K. V., Zhang, J. Y., Dinh, T. N., Strom, J. G., & Chen, Q. M. (2012) · Toxicological Sciences · doi:10.1093/toxsci/kfs070 · Cited by 8
Self-citationStatins and myocardial infarction: Type, dose, and administration time: Does it matter?
Παπαγεωργίου, Ν., Zacharia, E. M., Briasoulis, Α., Androulakis, E. S., & Tousoulis, D. (2016) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2016.01.001 · Cited by 8
Protein levels in Keap1-Nrf2 system in human failing heart
Konishi, M., Baumgarten, A., Ishida, J., Saitoh, M., Anker, S. D., & Springer, J. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.09.128 · Cited by 8
Cited by
Mechanisms of mitochondrial dysfunction and their impact on age-related macular degeneration
Kaarniranta, K., Uusitalo, H., Blasiak, J., Felszeghy, S., Kannan, R., Kauppinen, A., Salminen, A., Sinha, D., & Ferrington, D. (2020) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2020.100858 · Cited by 526
Nrf2/Keap1/ARE signaling: Towards specific regulation
Ulasov, A. V., Rosenkranz, A. A., Georgiev, G. P., & Sobolev, A. S. (2022) · Life Sciences · doi:10.1016/j.lfs.2021.120111 · Cited by 508
Mechanism of Ferroptosis and Its Role in Type 2 Diabetes Mellitus
Sha, W., Hu, F., Xi, Y., Chu, Y., & Bu, S. (2021) · Journal of Diabetes Research · doi:10.1155/2021/9999612 · Cited by 266
Silva, D. V. T. D., Baião, D. D. S., Ferreira, V. F., & Paschoalin, V. M. F. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2020.1822277 · Cited by 118
Tkaczenko, H., & Kurhaluk, N. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26031098 · Cited by 80
Metadata
- Authors
- Chen, Q. M., & Maltagliati, A. J.
- Venue
- Physiological Genomics
- Publisher
- American Physiological Society
- Published
- 2018-02-01
- Volume
- 50
- Issue
- 2
- Pages
- 77-97
- ISSN
- 1094-8341 (ISSN-L)
- 1531-2267
- OpenAlex
- W2769077130
- Cited by
- 474
- References
- 258
- FWCI
- 7.96
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.